Cim Investment Management Inc Bristol Myers Squibb CO Transaction History

Cim Investment Management Inc

$332 Million
Q3 2024

A detailed history of Cim Investment Management Inc transactions in Bristol Myers Squibb CO stock. As of the latest transaction made, Cim Investment Management Inc holds 14,746 shares of BMY stock, worth $830,199. This represents 0.23% of its overall portfolio holdings.

Number of Shares

14,746

Previous 15,174 2.82%

Holding current value

$830,199

Previous $630,000 21.11%

% of portfolio

0.23%

Previous 0.2%

24 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2024 Nov 25, 2024	SELL	$39.66 - $51.75 $16,974 - $22,149	-428 Reduced 2.82%	14,746 $763,000
Q2 2024 Aug 15, 2024	SELL	$40.25 - $52.99 $5,675 - $7,471	-141 Reduced 0.92%	15,174 $630,000
Q3 2023 Nov 14, 2023	SELL	$57.89 - $64.73 $19,335 - $21,619	-334 Reduced 2.13%	15,315 $888,000
Q2 2023 Aug 09, 2023	BUY	$63.71 - $70.74 $1,975 - $2,192	31 Added 0.2%	15,649 $1 Million
Q1 2023 May 16, 2023	BUY	$65.71 - $74.53 $405,102 - $459,477	6,165 Added 65.22%	15,618 $1.08 Million
Q4 2022 Feb 14, 2023	SELL	$68.48 - $81.09 $683,772 - $809,683	-9,985 Reduced 51.37%	9,453 $680,000
Q2 2022 Sep 02, 2022	SELL	$72.62 - $79.98 $7,552 - $8,317	-104 Reduced 0.53%	19,438 $1.5 Million
Q1 2022 May 17, 2022	SELL	$61.48 - $73.72 $87,117 - $104,461	-1,417 Reduced 6.76%	19,542 $1.43 Million
Q4 2021 May 19, 2022	SELL	$53.63 - $62.52 $1.14 Million - $1.33 Million	-21,326 Reduced 50.43%	20,959 $1.31 Million
Q4 2021 Feb 02, 2022	BUY	$53.63 - $62.52 $1.12 Million - $1.31 Million	20,959 Added 98.28%	42,285 $2.57 Million
Q3 2021 Nov 15, 2021	SELL	$59.17 - $69.31 $6,804 - $7,970	-115 Reduced 0.54%	21,326 $1.26 Million
Q2 2021 Aug 13, 2021	SELL	$61.91 - $67.42 $25,630 - $27,911	-414 Reduced 1.89%	21,441 $1.43 Million
Q1 2021 May 20, 2021	SELL	$59.34 - $66.74 $45,573 - $51,256	-768 Reduced 3.39%	21,855 $1.38 Million
Q4 2020 Feb 17, 2021	BUY	$57.74 - $65.43 $446,618 - $506,101	7,735 Added 51.95%	22,623 $1.4 Million
Q3 2020 Nov 16, 2020	SELL	$57.43 - $63.64 $8,384 - $9,291	-146 Reduced 0.97%	14,888 $898,000
Q2 2020 Aug 14, 2020	BUY	$54.82 - $64.09 $824,163 - $963,529	15,034 New	15,034 $884,000
Q4 2019 Feb 14, 2020	SELL	$49.21 - $64.19 $377,785 - $492,786	-7,677 Closed	0 $0
Q3 2019 Nov 14, 2019	SELL	$42.77 - $50.71 $33,873 - $40,162	-792 Reduced 9.35%	7,677 $389,000
Q2 2019 Aug 08, 2019	BUY	$44.62 - $49.34 $15,081 - $16,676	338 Added 4.16%	8,469 $384,000
Q1 2019 May 13, 2019	SELL	$45.12 - $53.8 $367,321 - $437,985	-8,141 Reduced 50.03%	8,131 $388,000
Q4 2018 Feb 05, 2019	SELL	$48.76 - $63.23 $31,694 - $41,099	-650 Reduced 3.84%	16,272 $846,000
Q3 2018 Nov 09, 2018	SELL	$55.19 - $62.25 $441 - $498	-8 Reduced 0.05%	16,922 $1.05 Million
Q2 2018 Aug 07, 2018	BUY	$50.53 - $62.98 $534,354 - $666,013	10,575 Added 166.4%	16,930 $937,000
Q1 2018 May 10, 2018	BUY	$59.92 - $68.98 $380,791 - $438,367	6,355 New	6,355 $402,000

Others Institutions Holding BMY

# of Institutions

2,537

Shares Held

1.47B

Call Options Held

31.6M

Put Options Held

35M

View Full List

About BRISTOL MYERS SQUIBB CO

Ticker BMY
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—General
Shares Outstandng 2,126,160,000
Market Cap $120B
Description
Bristol-Myers Squibb Company discovers, develops, licenses, manufactures, and markets biopharmaceutical products worldwide. It offers products for hematology, oncology, cardiovascular, immunology, fibrotic, neuroscience, and covid-19 diseases. The company's products include Revlimid, an oral immunomodulatory drug for the treatment of multiple my...

More about BMY

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Cim Investment Management Inc, based on Form 13F filings with the SEC.

News

Stay updated on Cim Investment Management Inc with notifications on news.

Account

Cim Investment Management Inc Bristol Myers Squibb CO Transaction History